Last reviewed · How we verify

NCT06737861

Buerger Exercises With Whole Body Vibration in Diabetic Peripheral Neuropathy

Completed NA Last updated 22 August 2025
What this trial tests

NA trial testing Group A in Diabetic Peripheral Neuropathic Pain in 64 participants. Completed in 30 July 2025.

Timeline
20 December 2024
Primary endpoint
30 July 2025
30 July 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment64
Start date20 December 2024
Primary completion30 July 2025
Estimated completion30 July 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 50 to 70, any sex, with Diabetic Peripheral Neuropathic Pain or Balance Changes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to determine if a combined intervention of Buerger exercises and whole-body vibration therapy can improve pain, circulation, and balance in adults with diabetic peripheral neuropathy. Participants will: Perform Buerger exercises three times daily in both groups. Receive whole-body vibration therapy three times per week (intervention group only). Complete assessments at baseline, the 4th, 8th, 12th weeks, and a follow-up at the 16th week. Outcome measures include pain rating, ankle-brachial index, balance scale, and timed mobility test. Statistical analyses will assess within-group and between-group effects based on data distribution.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Group A

Trials testing the same drug.

Other recruiting trials for Diabetic Peripheral Neuropathic Pain

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06737861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing